Vitamin C in prophylaxis and adjunctive treatment of COVID 19 |
Journal Updates
eMediNexus Coverage from: 
Vitamin C in prophylaxis and adjunctive treatment of COVID 19

0 Read Comments                

Severe acute respiratory syndrome coronavirus 2 is known to cause respiratory infection, which can be followed by severe systemic illness. Early use of Low dose (0.5–2 g/d) vitamin C has shown benefits in severe acute respiratory syndrome coronavirus 2 infections.Cytokine storm involving interleukin-6 and endothelin-1, which causes Severe late forms of coronavirus disease 2019, have also observed to be benefitted/reduced by the use of Vitamin C (especially at high doses).Vitamin C suppleme...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now